stonkbuilderCOMMUNITY NeuralinkVideosR03-DWvWmAY
Independent Research Notice: Independent StonkBuilder Community research publication. Not affiliated with, operated by, or endorsed by Neuralink Corp. or PreStocks. Neuralink devices are investigational and have not received FDA marketing authorization. Nothing here is medical, legal, or financial advice. PreStocks tokens are not Neuralink shares, confer no shareholder rights, and are unavailable to U.S. persons and residents of prohibited jurisdictions.

Neuralnauts | Audrey: technical breakdown, key moments and clinical context

Released on 26 August 2026 ('Neuralnauts | Audrey', 1:51), this profile revisits Audrey—the first female participant in the PRIME clinical trial—showing how her daily fluency with Telepathy cursor control has evolved into creating intricate digital artwork and illustrations independently at home.

26 Aug 2026Published dateOfficial @neuralink Video · 1:51
R03-DWvWmAYYouTube Video IDChannel UCLt4d8cACHzrVvAz9gtaARA · Embeddable (200 OK)
Tier 1Evidence classHuman Trial (PRIME)
Movement & computer controlPrimary topicPaired with /neuralink/telepathy-computer-control
Key points
  • Primary record: Official @neuralink video (R03-DWvWmAY) published on 26 Aug 2026 (duration 1:51).
  • What it shows: Sustained, fine-grained 2D trajectory control suitable for freehand illustration rather than just coarse grid clicking.
  • Technical pathway: Motor cortex hand area → N1 Bluetooth telemetry → 2D cursor velocity & pressure/click control → illustration app.
  • Evidence boundary: Participant experience profile in PRIME (NCT06429735); individual creative workflow.

Watch the official video record

Poster illustration for Neuralnauts | Audrey
Official @neuralink Video 26 Aug 2026 · 1:51 Tier 1 · Human Trial (PRIME)
Neuralnauts | Audrey

Click to load the privacy-enhanced youtube-nocookie.com player. No third-party cookies or requests are sent until you press play.

Watch on YouTube ↗
Source: Neuralink (@neuralink) · Channel UCLt4d8cACHzrVvAz9gtaARA · Video R03-DWvWmAY · Checked 30 Oct 2026 Direct YouTube link ↗

Official upload from @neuralink (26 Aug 2026, 1:51).

Read verbatim official @neuralink YouTube description & caption provenance

Caption & verification basis: English manual + auto-generated captions (Official video playback, English caption track, official description, and primary Neuralink disclosures).

With Neuralink, Audrey is creating art with her mind.

Learn more about Neuralink’s clinical trials: https://neuralink.com/trials/

Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities. This video features voluntary clinical trial participants sharing their personal experiences, which may not reflect all participants or future outcomes.

Technical pathway and evidence classification

Video notes · 26 Aug 2026 · Video (1:51) Neuralnauts Participant Profile · Digital Art (Audrey)
EVIDENCE CLASSIFICATION Tier 1 · Human Trial (PRIME) Video ID: R03-DWvWmAY Published: 26 Aug 2026 (1:51) PRIMARY SUBSYSTEM Movement & computer control (Telep Channel: @neuralink (verified) Embed: Embeddable (youtube-nocookie) INTERPRETATION BOUNDARY Investigational Context Not FDA marketing approval Verify against clinical registries
Technical pathway Signal & hardware chain

Motor cortex hand area → N1 Bluetooth telemetry → 2D cursor velocity & pressure/click control → illustration app

Analytical scope What to keep in mind

Participant experience profile in PRIME (NCT06429735); individual creative workflow.

Timestamped breakdown and key moments

Sequential moments in Neuralnauts | Audrey (1:51)
TimestampSegment / eventWhat happens in the segment
00:00Audrey's creative workflowShows freehand digital brush strokes controlled entirely via cortical movement intent.
00:55Precision cursor trajectoryHighlights fine path control without physical hand or stylus motion.
01:25Independent daily useReflects on regaining creative expression 20 years after a cervical spinal cord injury.

What this video demonstrates—and what it does not establish

What this video demonstrates

  • Sustained, fine-grained 2D trajectory control suitable for freehand illustration rather than just coarse grid clicking.
  • Longitudinal home usability across months of participation in the PRIME study.

Scope limits & what it does not establish

  • Qualitative participant vignette; pair with quantitative BPS metrics in the Summer/Fall 2025 updates.

How this fits into Neuralink's broader clinical and hardware roadmap

This video sits inside the Movement & computer control (Telepathy) research track on StonkBuilder's independent Neuralink hub. All Neuralink hardware (the N1 implant and R1 surgical robot) and clinical programs (PRIME NCT06429735, CONVOY, and VOICE NCT07224256) remain investigational and have not received FDA commercial marketing authorization. Read our full companion guide at Movement & computer control (Telepathy) for cohort context.

Sources checked 30 Oct 2026

Sources and official records

  1. [1] Neuralink YouTube (2026-08-26): Neuralnauts | Audrey · Verified 30 Oct 2026
  2. [2] Neuralink: Official YouTube Channel (@neuralink, UCLt4d8cACHzrVvAz9gtaARA) · Verified 30 Oct 2026
  3. [3] Neuralink: Official website and investigational device notice · Verified 30 Oct 2026
  4. [4] Neuralink: Clinical Trials and Patient Registry · Verified 30 Oct 2026
  5. [5] ClinicalTrials.gov: The PRIME Study (NCT06429735) · Verified 30 Oct 2026
  6. [6] Neuralink: Two Years of Telepathy (28 Jan 2026) · Verified 30 Oct 2026